Recent Articles from Investor's Business Daily

Updates on the Terafab project could give investors a sense of how much money Tesla intends to spend in the future.

Agios Pharmaceuticals dropped its next-generation sickle cell drug Tuesday after a failed Phase 2 study. Agios stock tumbled.

TSMC stock jumped on a report that the semiconductor manufacturing giant is planning to raise prices in 2027.

3M stock led the Dow Jones Industrial Average on strong earnings and faster growth, helped by its new optical technology for data centers.

Nebius stock popped after Nvidia disclosed a 9% stake in the cloud computing specialist in a regulatory filing.

Danaher stock plummeted Tuesday after reporting what one analyst called "surprisingly soft" bioprocessing sales.

The Clarity Act nears a Senate vote this week after President Trump reportedly agreed to a debated ethics provision.

Novartis stock jumped early Tuesday on better-than-expected second-quarter metrics, partially driven by Cosentyx.

Interactive Brokers also on tap. Both brokerages are close to buy points.

One of Rhode Island's most-wanted fugitives was captured Monday after apparently hiding out for 20 years as a biotech exec.

Rare earth mining output outside China could triple by 2035, the IEA says.

Watch these "Growth Industry" sectors instead.

IBM stock has seen its price target cut by at least five analysts since it pre-released Q2 results last week, which sent the stock tumbling.

Breakout stock Select Water Solutions has nearly doubled in 2026.

ARK Invest bought more SpaceX on Friday after its scrubbed Starship test.

Boeing announced orders for nearly 150 planes as the Farnborough Airshow began on Monday. Airbus, RTX, eVTOL makers secured deals.

Micron is now the No. 1 contributor to S&P 500 earnings.

Earnings? Tesla investors want updates about robotaxis and Optimus robots.

The investor pain around IBM stock's plunge can be managed. Here's how Brian Shannon of Alphatrends.net advises investors to handle it.

Christopher Nolan's new release had a record IMAX opening.

Tempus AI pledged to buy cancer diagnostics outfit Personalis for $1.5 billion on Monday. But shares of both medtech companies skidded.

Crude futures were little changed Monday, but don't be fooled.

AMD stock rallied Monday after the chip giant announced an expanded AI partnership with technology giant Microsoft.

The FDA agreed to review the company's muscular dystrophy drug.

Google is developing a new AI accelerator with built-in software coding from its Gemini model, said a report. Google stock rose on the news.

The mission will mark a Starlink first.

Shareholders "increasingly focused" on robotaxi, Optimus investments.

IREN lifts cloud revenue target, as it upgrades contracts with AI leaders.

U.S.-listed Alibaba Group stock climbed after the Chinese tech giant touted its latest AI model as trailing only Anthropic.

Read inspirational quotes about following through on your goals, planning daring moves and getting started.

Look past AI buildout plays, but note this one resilient chip stock.

What excited investors about insurance firm Travelers is that it reported a whopping 54% surge in earnings Friday.

Meta stock trimmed earlier losses after the New York Times reported the tech giant is in talks with Anthropic for a cloud deal.

The Philadelphia semiconductor index, known as SOX, fell into bear market territory on Friday but chip stocks later rebounded.

Goldman, GE Aerospace, Taiwan Semi, IBM were notable movers on news.

Gilead stock is closely tied to its HIV treatments. But with Biktarvy's patent expirations looming, can the giant survive?

Netflix stock fell after the video streamer disappointed investors with soft Q3 guidance and reduced disclosures.

Cathie Wood's ARK Invest has a significant position in X-Energy across multiple ETFs, since its April IPO. Shares fell over 13% this week.

Personalis stock popped Friday on a rumor Merck and at least two other suitors are trying to buy the small genomics company.

Meta is reportedly hiring an AWS executive, following news that it could explore a cloud business helped boost Meta stock.

MSTR stock has essentially lost its valuation premium to its bitcoin holdings as its financial engineering backfires.

A well-designed product gets you into the game. But winning in business means getting others to see your product's merit.

Google stock fell amid a report the internet giant is behind schedule on delivering Gemini 3.5 Pro, its most powerful flagship AI model, as rivals gain momentum.

Intuitive Surgical issued lackluster procedure guidance for the year on Thursday, leading the stock to take a dive.

Netflix missed Wall Street's target for second-quarter revenue and guided lower than views for Q3. Netflix stock fell in extended trading.

S&P 500's Prologis looks past warehouses and logistics to AI data centers.

Oracle stock fell to a 52-week low Thursday as the enterprise technology giant's stock slump shows no signs of ending.

President Trump will meet to discuss ethics concerns regarding the Clarity Act ahead of a potential Senate vote next week.

Amazon stock and Google are buys because of massive AI distribution while Meta has to prove its strategy, Wedbush says.

Chip stocks fell hard for the second straight trading session on Thursday, led by declines for memory-chip makers such as SK Hynix.

SpaceX on Thursday will conduct its 13th Starship test flight, following the May explosion, and launch satellites for the SDA. SPCX stock slides below listing price.

Eli Lilly tripped into the psychedelics space Thursday with the up to $3.8 billion acquisition of AtaiBeckley.

Ahead of next week's earnings call, Tesla retail investors wanted updates from CEO Elon Musk on robotaxi expansion and Cybercab production.

Merck won the first-ever approval for a PCSK9 pill to lower LDL cholesterol, starting a new rivalry with injection-makers.

Abbott stock jumped early Thursday on better-than-expected second-quarter metrics. The company also raised its profit view.

Uber stock was slightly higher after it announce a deal for Delivery Hero, following weeks of negotiations with the rival platform.

FDA advisors will debate the merits of seven peptides next week. The discussion could have an impact on Lilly and Novo.

On Valentine's Day in 1988, Dan Jansen was awakened at Calgary's Olympic Village with terrible news: His sister was dying of leukemia.

UNH stock surged past a buy point, leading the Dow Jones, after Q2 earnings trounced estimates amid lower-than-expected benefit costs.

Taiwan Semiconductor Manufacturing beat analyst estimates for the second quarter and with its outlook. But TSM stock fell.

Investors will watch how well J.B. Hunt is capitalizing on intermodal recovery.

The Anthropic IPO could launch by October, according to a Bloomberg report. That's despite rival OpenAI delaying its plans.

Memory stocks plunged on Wednesday along with shares of other hardware providers for AI data centers. Sandisk stock was a big decliner.

Energy innovators NXT and POWL are rising on demand for data center stocks and analysts upgrades at Guggenheim and GLJ.

SpaceX stock continued its multi-week downtrend Wednesday, officially falling below its IPO listing price.

Army official says the Pentagon is working with Anduril and other private defense contractors on hypersonic missile and technology efforts.

Three Wall Street analysts lowered their price targets on Microsoft stock on Wednesday as the software giant faces AI-related uncertainties.

The market opportunity for 3M's data center technology has rapidly escalated.

Morgan Stanley picked its topped three defense names that included Northrop Grumman, FTAI Aviation and a space company with 100% upside.

IBM stock ticked slightly lower Wednesday morning, following a brutal sell-off on Tuesday that followed IBM's surprise Q2 earnings release.

Celcuity just won FDA approval for its first drug, a treatment for metastatic breast cancer.

Nvidia stock is approaching a proper buy point as the artificial intelligence chip leader received some reassuring news this week.

Merck stock popped Wednesday on the back of positive test results for a new treatment combo in a common form of lung cancer.

Analysts expects major gains from Unusual Machines stock. Karman Holdings to join this S&P index. Redwire climbs on drone order.

Elevance Health stock dived and inflected UNH and other S&P 500 health insurers after it easily beat Q2 forecasts, but only slightly hiked its outlook.